Valuation Methodologies in Life Sciences hosted by Brex

Description

Guest Speaker: John Selig, Managing Partner at WaveEdge Capital 
 
Synopsis: 
Why is the valuation of early-stage life sciences companies so complex?

This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.
If you are an entrepreneur who is, or will be, raising financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the investing sector, you'll benefit from this overview of the key concepts used in life sciences valuation discussions. This discussion will cover the various valuation methodologies used to assign a value to life science businesses and assets, the methodologies used in particular by pharma partners and venture capitalists, and an explanation of three fundamental concepts in life sciences valuation: risk-adjustment, cost of capital and net present value.